Kiran Sury, MD, discusses patient selection, durability, and adverse events with ProACT for male stress urinary incontinence.
|Articles|August 15, 2022
Lt. Col. Matthew Banti, MD, discusses his unique experience as a urologist in the military
On this podcast, Lieutenant Colonel Matthew Banti, MD, FACS, a recent graduate of the Urologic Oncology fellowship at the University of Kansas Health System, is interviewed about his career journey as a urologist in the United States Army.
Advertisement
In this podcast interview, Lt. Col. Matthew Banti, MD, FACS, a recent graduate of the Urologic Oncology fellowship at the University of Kansas Health System, provides great insight on his unique journey. He discusses the life of a urologist in the Army and the characteristics that make an optimal physician within the military. Dr. Banti also offers his thoughts on his life overall as a urologic oncologist and how he can best serve the country as an extremely specialized professional.
Advertisement
Related to this article
enGene expects to initiate a BLA submission by the end of 2026.
The designation was supported by findings from the phase 2 Co-PSMA trial, the phase 1/2 COBRA trial, and real-world evidence.
American Cancer Society updates prostate cancer screening guidelines, recommends regular PSA testing
The updated guidance recommends routine PSA-based screening every 2 years for average-risk men aged 50 to 69 years and annual screening beginning at age 45 for Black men or men with a strong family history of prostate cancer.
Earlier genetic testing in men with very low sperm counts may spare unnecessary testing or surgery, according to Ronald Anglade, MD.
Vignesh Packiam, MD, discusses optimizing BCG treatment in high-risk NMIBC, including patient selection for combination immunotherapy and treatment-related trade-offs.
A national survey of US military service members and veterans with NMIBC found that more than half were diagnosed by age 50, while 63% reported treatment access barriers.
VOLGA results raise the question of treatment de-intensification in perioperative MIBC care, according to Suzanne B. Merrill, MD, FACS.
Advertisement
Advertisement
Trending on Urology Times
1
American Cancer Society updates prostate cancer screening guidelines, recommends regular PSA testing
2
FDA grants De Novo authorization to Virtuoso Robotic System for bladder tumor resection
3
BCG-naïve NMIBC: Optimizing initial treatment selection
4
FDA grants breakthrough therapy designation to 64Cu-SAR-bisPSMA for recurrent prostate cancer imaging
5